Adaptive Biotechnologies's market cap is currently ―. The company's EPS TTM is $-1.33; its P/E ratio is -4.10; Adaptive Biotechnologies is scheduled to report earnings on November 14, 2023, and the estimated EPS forecast is $-0.32. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	$ 48.93M	$ 37.65M	$ 55.20M	$ 47.83M	$ 43.66M
Gross Profit	$ 31.02M	$ 18.97M	$ 38.61M	$ 32.92M	$ 30.44M
EBIT	$ -44.21M	$ -54.17M	$ -39.19M	$ -44.67M	$ -52.50M
EBITDA	$ -40.47M	$ -50.35M	-	$ -39.28M	$ -47.31M
Net Income Common Stockholders	$ -47.81M	$ -57.70M	$ -40.13M	$ -45.28M	$ -52.05M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 417.23M	$ 440.69M	$ 498.20M	$ 508.08M	$ 383.74M
Total Assets	$ 764.52M	$ 791.46M	$ 773.17M	$ 884.21M	$ 806.63M
Total Debt	$ 103.52M	$ 105.78M	$ 108.00M	$ 109.05M	$ 111.34M
Net Debt	$ -313.71M	$ -334.91M	$ -390.19M	$ -399.03M	$ -272.40M
Total Liabilities	$ 368.57M	$ 367.51M	$ 856.62M	$ 396.39M	$ 288.32M
Stockholders Equity	$ 396.04M	$ 424.02M	$ 464.17M	$ 487.84M	$ 518.30M
Cash Flow	-
Free Cash Flow	$ -27.25M	$ -62.08M	$ -32.58M	$ -47.84M	$ -52.36M
Operating Cash Flow	$ -23.56M	$ -59.15M	$ -30.04M	$ -42.41M	$ -47.06M
Investing Cash Flow	$ 37.32M	$ 62.98M	$ -97.54M	$ 58.02M	$ 4.75M
Financing Cash Flow	$ 1.47M	$ 672.00K	$ 6.00K	$ 125.52M	$ 3.99M

Currency in USD

Adaptive Biotechnologies Earnings and Revenue History

Income Statement >

Adaptive Biotechnologies Debt to Assets

Balance Sheet >

Adaptive Biotechnologies Cash Flow

Cash Flow >

Adaptive Biotechnologies Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing